越南经口腔前庭入路甲状腺内镜手术的结局与长期随访
该前瞻性研究纳入2018年7月至2021年4月在河内医科大学医院接受TOETVA的326例甲状腺癌或良性结节患者,评估手术结局与长期随访。结果显示暂时性低钙血症4.8%、暂时性声嘶3.6%、下巴麻木2.8%,无永久性并发症,中位随访12个月无复发。
要点
- TOETVA可用于良性甲状腺结节及早期分化型甲状腺癌。
- 术后暂时性低钙血症4.8%、声嘶3.6%、下巴麻木2.8%,无永久并发症。
- 中位随访12个月无复发,支持该术式在越南的推广应用。
核心结论
- TOETVA是治疗良性甲状腺结节及早期分化型甲状腺癌的创新技术,肿瘤学结果、并发症及满意度支持其在越南广泛应用。
研究设计与样本
- 前瞻性研究纳入2018年7月至2021年4月河内医科大学医院肿瘤与姑息治疗科326例因甲状腺癌或良性结节接受TOETVA的合格患者。
主要发现
- 平均年龄36.9±9.8岁,231例(70.9%)为分化型癌,95例(29.1%)为良性肿瘤。
- 癌组中12例(5.2%)术中诊断为T3b,219例(92.2%)按AJCC第8版诊断为T1。
- 癌组平均清扫淋巴结6.1±4.1枚(范围0-21),发现转移淋巴结2.6±1.8枚(范围1-8),最大径小于2 mm。
- cN0期甲状腺癌患者中81例(35%)存在隐匿性淋巴结转移,T1组为34.2%,T3b组为50%。
- 术后中位住院5.4±0.7天,暂时性低钙血症12例(4.8%)、暂时性声嘶9例(3.6%)、下巴麻木7例(2.8%),无永久性并发症。
临床怎么用
- 对于良性甲状腺结节及早期分化型甲状腺癌,TOETVA可作为可选术式,需关注暂时性低钙血症、声嘶及下巴麻木。
- cN0期甲状腺癌患者隐匿性淋巴结转移率较高(35%),T3b组达50%,术中应规范行中央区淋巴结清扫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The transoral endoscopic thyroidectomy by vestibular approach (TOETVA) has been developed for early-stage thyroid cancer treatment as well as benign thyroid nodules worldwide including Viet Nam, with low rate of complications and excellent results. However, there has not been any comprehensive studies with a large number of patients and long-term follow-up in our country. Therefore, we conducted this study to evaluate the results of treatment by TOETVA for benign and malignant lesions of thyroid gland in Viet Nam. METHODS: A prospective study was performed on 326 eligible patients who underwent TOETVA due to thyroid cancer and benign thyroid nodules in Department of Oncology and Palliative Care, Hanoi Medical University Hospital from July 2018 to April 2021. The clinical, surgical, and pathological characteristics, postoperative complications, and visual analog scale (VAS, 0-10 cm) score in day 1, 4, and 7 after surgery, long-term oncological and surgical outcomes were recorded. RESULTS: The mean age was 36.9 ± 9.8 years. 231 patients (70.9%) were diagnosed with differentiated cancer and 95 patients (29.1%) were diagnosed benign tumors of thyroid gland. In the cancer group, 12 patients (5.2%) undergone TOETVA had T3b-intraoperative-stage diagnosis, 219 patients (92.2%) were diagnosed T1 according to AJCC 8th. After 1 month of surgery, among thyroid cancer patients, there was no abnormality reported by thyroid scintigraphy and neck ultrasound as well as in unstimulated-Tg and anti-Tg values. The mean number lymph-node dissected in the cancer group was 6.1 ± 4.1 (range 0-21 nodes). However, only 2.6 ± 1.8 metastasis nodes were discovered (range 1-8 nodes), and the maximum size of these nodes was less than 2 mm. 81 patients presented occult lymph-node metastasis among thyroid cancer patients with cN0 stage (account for 35%). The occult lymph-node metastasis was 34.2% and 50% in patients diagnosed with T1 and T3b groups, respectively. The median postoperative hospital stay was 5.4 ± 0.7 days. Postoperatively, transient hypoparathyroidism was recorded in 12 patients (4.8%), transient hoarse was noted in 9 patients (3.6%), and numb chin was identified in 7 patients (2.8%). No permanent complication was noted. VAS score on first postoperative day was 4.5 ± 0.8. Median follow-up time was 12 (3-25) months. No recurrence was recorded. CONCLUSIONS: TOETVA is an innovative and revolutionary technique in the treatment of benign thyroid nodules, as well as early-stage differentiated thyroid cancer. The results of oncology, postoperative complications, and satisfied outcomes supported the wide application of TOETVA in Viet Nam.
引用
- Nguyen HX, Nguyen HX, Nguyen TTP, et al. Transoral endoscopic thyroidectomy by vestibular approach in Viet Nam: surgical outcomes and long-term follow-up. Surg Endosc. 2021. PMID: 34622296. doi:10.1007/s00464-021-08759-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。